You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美股異動丨吉利德科學盤前漲超2% 艾滋病預防明星藥獲美國FDA批準
格隆匯 06-20 16:12

吉利德科學(GILD.US)盤前漲超2.1%,報110.3美元。消息面上,吉利德科學宣佈,備受業界關注的HIV-1衣殼抑制劑來那卡帕韋(Lenacapavir,商品名Yeztugo)已經獲得美國食品藥品監督管理局批準用於暴露前預防(PrEP)用藥。在一項後期試驗中,使用來那卡帕韋的兩千多人中僅出現兩例感染,使得HIV感染風險有效降低96%。在另一項針對生理女性、且自我認知爲女性的試驗中,所有參與者均未感染病毒,有效性達到100%。(格隆匯)

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account